EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy

Karlien Mul iD, Michael P McDermott, Russell J Butterfield, Bakri Elsheikh, Kate Eichinger, Nicholas E Johnson, Doris G Leung iD, Samantha LoRusso, Leann Lewis, William B Martens, Perry B Shieh, Leo H Wang iD und 4 weitere

Annals of Neurology · 2026

DOI: 10.1002/ana.78182 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Neurology, 2026. Verfasst von Karlien Mul und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Muscular Dystrophy, Facioscapulohumeral, Disease Progression, Muscle, Skeletal, Electric Impedance. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Muscular Dystrophy Association (MDA) Clinical Research Network, National Institute of Neurological Disorders and Stroke (NINDS), FSHD Society, Friends of FSH Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Targeted therapies for facioscapulohumeral muscular dystrophy (FSHD) are progressing through clinical trials. Electrical impedance myography (EIM) provides a noninvasive biomarker of muscle composition that may be valuable especially in early phase trials. This study evaluated EIM data from a multicenter FSHD cohort over 24 months.

Methods

Adult patients with FSHD at 8 sites underwent EIM in 6 muscles bilaterally (deltoid, biceps, triceps, vastus lateralis, tibialis anterior, and medial gastrocnemius). EIM outcomes phase and reactance (50 and 100 kHz [kilohertz] frequencies) and 50 of 211 kHz phase ratio were evaluated for reliability, correlations with clinical measures, and sensitivity to change.

Results

One hundred fifty‐seven patients (53% male patients) were included. Test–retest reliability was excellent for all EIM outcomes (intraclass correlation coefficient [ICC] ≥0.94). Phase outcomes strongly correlated with the FSHD‐composite outcome measure (FSHD‐COM; r ≤ −0.69) and Motor Function Measure Domain 1 (MFM1; r ≥ 0.75); reactance outcomes exhibited moderate correlations with the FSHD‐COM ( r ≥ –0.41) and MFM1 ( r ≤ 0.44). Mean declines in phase and phase ratio were apparent at 12 months (eg, –0.25, 95% confidence interval [CI] = –0.45 to –0.05 at 50 kHz), and further progressed through 24 months (–0.66, 95% CI = –0.92 to –0.40] at 50 kHz and –0.65 [95% CI = –0.87 to –0.44] at 100 kHz; both p < 0.0001). Reactance changes were smaller and not significant: –0.21 (95% CI = –0.44 to 0.02) at 50 kHz and –0.13 (95% CI = –0.35 to 0.10) at 100 kHz.

Interpretation

EIM phase outcomes are reliable, valid, and sensitive to change over 12 to 24 months, supporting their potential utility as biomarkers in FSHD clinical trials. ANN NEUROL 2026;99:1545–1554

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, FacioscapulohumeralDisease ProgressionMuscle, SkeletalElectric ImpedanceMyographyHumansMaleFemaleMiddle AgedAdultReproducibility of ResultsAgedElectromyographyCohort Studies

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY.
  • Department of Neurology, University of Utah, Salt Lake City, UT.
  • Department of Pediatrics, University of Utah, Salt Lake City, UT.
  • Department of Physical Therapy and Athletic Training, University of Utah, Salt Lake City, UT.
  • Department of Neurology, The Ohio State University, Columbus, OH.

ORCID-Profile: Karlien Mul, Doris G Leung, Leo H Wang, Rabi Tawil

Förderung

  • Muscular Dystrophy Association (MDA) Clinical Research Network
  • National Institute of Neurological Disorders and Stroke (NINDS)
  • FSHD Society, Friends of FSH Research
  • AFM-Téléthon
  • NIAMS NIH HHS

Zitieren

APA

Mul, K., McDermott, M. P., Butterfield, R. J., Elsheikh, B., Eichinger, K., Johnson, N. E., Leung, D. G., LoRusso, S., Lewis, L., Martens, W. B., Shieh, P. B., Wang, L. H., Walker, M., Tawil, R., Statland, J. M., & ReSolve Investigators of the FSHD‐CTRN (2026). Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy. Annals of Neurology. https://doi.org/10.1002/ana.78182

Vancouver

Mul K, McDermott MP, Butterfield RJ, Elsheikh B, Eichinger K, Johnson NE, et al. Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy. Annals of Neurology. 2026. doi:10.1002/ana.78182

BibTeX
@article{Mul2026,
  author = {Mul, Karlien and McDermott, Michael P and Butterfield, Russell J and Elsheikh, Bakri and Eichinger, Kate and Johnson, Nicholas E and Leung, Doris G and LoRusso, Samantha and Lewis, Leann and Martens, William B and Shieh, Perry B and Wang, Leo H and Walker, Michaela and Tawil, Rabi and Statland, Jeffrey M and ReSolve Investigators of the FSHD‐CTRN, ReSolve Investigators of the FSHD‐CTRN},
  title = {Electrical Impedance Myography Detects Disease Progression over 12 to 24 Months in Facioscapulohumeral Muscular Dystrophy},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78182}
}
Kostenlos starten →